Search results

• Investor seminar on our sustainability strategy

  20 October 2020: Steve Foots, CEO and other senior members of our management team provided a comprehensive overview of our 2030 sustainability Commitment.

• Shareholder centre

  Useful information for Croda Shareholders.

• Types of careers at Croda

  Learn more about the types of careers available at Croda.

• Shareholder information

  Keep up to date with shareholder and investor information.

• Working with Croda

  Learn more about working with Croda.

• Making every minute count

  Take a look at how employees across the Croda Group have spent their 1% Club time helping their communities.

• Regulatory news

  Our most recent announcements to the stock exchange.

• International Day of Women and Girls in Science

  At Croda, we recognise that by championing gender equality in STEM, we can adopt a future where talent determines success; while promoting inclusivity, and empowering the next generation of female scientists, engineers, and innovators.

• Ratings and frameworks

  View our ratings and frameworks which help to shape our sustainability programme.

• Annual Report

  Find our 2023 Annual Report here

• Sustainability Impact Report 2024

  Find our 2024 Sustainability Impact Report here

• Steve Foots, CEO Sustainability Statement 2024

  One of our core philosophies is to take a leadership position in sustainability and innovation in our chosen markets.

• Key Performance Indicators

  Explore Croda’s key performance indicators for 2025, highlighting progress across financial performance, sustainability and strategic priorities.

• Steve Foots, Group Chief Executive Letter

  We are focused on delivery and modernisation, ensuring rigorous cost discipline and driving operational efficiencies to continue our long record of strong performance.

• Croda unveils Matrixyl® Neolide™, an iconic peptide with smarter delivery

  Croda introduces Matrixyl® Neolide™, an iconic peptide with smarter delivery, designed to maximise performance and unlock new possibilities in advanced skin care.

• First quarter 2026 sales in line with expectations

  Croda International Plc (“Croda” or the “Group”) today provides an update on its sales performance in the first quarter of 2026 (the three months ended 31 March 2026).

• Danuta Gray, Chair's Letter 2024

  The Board and shareholders are aligned that the Company’s priorities should be execution and operational delivery to grow earnings and improve returns on invested capital.

• Croda acquired crop enhancement company Plant Impact

  Plant Impact identifies ways to improve the yield and quality of crops by stimulating or moderating plant responses in both healthy and stressed crops during key growth stages.

• Acquisition of global vaccine adjuvant specialist

  Vaccine adjuvants are a natural extension to Croda’s market leading, high-purity excipient delivery systems in its Health Care business., these adjuvants represent a niche, high-growth market.

• Croda acquires marine biotechnology specialists Nautilus

  World class scientists, focusing on using marine microbial biodiversity to discover novel actives and materials for applications across all Croda market sectors.